UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Hippocampal Neurogenesis in Human Subjects
Completed
- Conditions
- Hippocampal Neurogenesis in Cocaine Addiction
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT02028273
- Locations
- 🇺🇸
UT Southwestern Medical Center at Dallas, Division on Addictions, Dallas, Texas, United States
Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus
Phase 2
Completed
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Dietary Supplement: Fish OilDietary Supplement: Olive Oil
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2013-12-27
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT02021513
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
The Glucose Transporter Type I Deficiency (G1D) Registry
Completed
- Conditions
- GLUT1 Deficiency SyndromeGlucose Transporter Type 1 Deficiency SyndromeGlucose Transporter Type1 (GLUT-1) DeficiencyGLUT-1 Deficiency Syndrome
- Interventions
- Other: No intervention
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 471
- Registration Number
- NCT02013583
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Phase 2
Completed
- Conditions
- Hypertension
- Interventions
- Procedure: MicroneurographyProcedure: Rhythmic handgrip exerciseProcedure: Sustained hand gripProcedure: Forearm blood flowProcedure: Arm cycling exerciseProcedure: Cold Pressor test
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT01996449
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer
Phase 1
Completed
- Conditions
- Early-stage Glottic Larynx Cancer
- Interventions
- Radiation: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT01984502
- Locations
- 🇺🇸
University Of Texas Southwestern Medical Center, Dallas, Texas, United States
A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients
Phase 1
Terminated
- Conditions
- Melanoma
- Interventions
- Drug: Arm B-Ipilimumab 3mg/kg IV over 90 minutes day 1 followed three weeks later by ipilimumab every 3 weeks x 3.Drug: Arm A-Bavituximab 3mg/kg IV over 90 minutes weekly x 3 followed by Bavituximab 3mg/kg IV over 90 minutes weekly x 12 plus ipilimumab 3mg/kg IV
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2016-12-29
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 3
- Registration Number
- NCT01984255
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01979133
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
Phase 1
Completed
- Conditions
- Advanced Breast Cancer
- Interventions
- Drug: PD-0332991 and T-DM1
- First Posted Date
- 2013-11-05
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT01976169
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Phase 4
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2013-10-22
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 157
- Registration Number
- NCT01966978
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
Withdrawn
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT01963949
© Copyright 2025. All Rights Reserved by MedPath